Richard Klein to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Richard Klein has written about Diabetes Mellitus, Type 2.
Connection Strength
0.469
-
Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins. J Clin Lipidol. 2022 Mar-Apr; 16(2):173-183.
Score: 0.102
-
Deoxysphingolipids Upregulate MMP-1, Downregulate TIMP-1, and Induce Cytotoxicity in Human Schwann Cells. Neuromolecular Med. 2022 09; 24(3):352-362.
Score: 0.101
-
Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort. J Diabetes Complications. 2019 10; 33(10):107410.
Score: 0.086
-
Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients. J Diabetes Complications. 2014 May-Jun; 28(3):353-9.
Score: 0.058
-
Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial. J Diabetes Complications. 2013 Nov-Dec; 27(6):627-32.
Score: 0.057
-
'Lipoproteins, glycoxidation and diabetic angiopathy'. Diabetes Metab Res Rev. 2004 Sep-Oct; 20(5):349-68.
Score: 0.031
-
Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 2003 Feb; 52(2):453-62.
Score: 0.027
-
Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes. 2006 Jan; 55(1):249-59.
Score: 0.008